Legal and Ethical Considerations in Marketing Product Safety and Intellectual Property

¶ … Marketing, Product Safety, and Intellectual Property

Ethical issues relating to marketing and advertising, intellectual property, and regulation of product safety

Various organizations often find themselves in the wrong side of the law when undertaking their various business practices relating to marketing and advertisement. It is the desire of every company to have its product known to as many consumers as possible. This often drives them to employ diverse marketing and advertisement strategies that raise some critical ethical issues. The same also applies to the protection of someone's intellectual property and enhancing product safety. This study focuses on deceit, unfairness, and advertising and children as some of the critical ethical issues related to marketing and advertising, intellectual property, and regulation of product safety

Deceit

The Federal Trade Commission is a government branch established to battle deception in advertising. As illustrated in the FTC Act of 1914, the FTC is answerable for controlling unreasonable practices in advertising. Moreover, the FTC was also empowered to manage deceptive or industrially unjustifiable advertisements. Working within the court frameworks, magistrates of the FTC hear cases with respect to violations of the FTC Act. The FTC is also answerable for making guidelines intended to counsel advertisers on reasonable advertising practices (Weiss, 2009).

While seeking to combat deceptive advertising, the FTC ensures that an advertisement is undoubtedly misleading whilst constantly evaluating the messages passed on to purchasers. In case the FTC confirms that the advertisements contrasts excessively with what it represents, it is acknowledged misleading. When doing this, it is important to consider the contents of the advertisement message and comparison with the qualities of the real item. Surveys are used routinely upon request to determine the contents of such message. The FTC will survey the consumers randomly and asking questions concerning an advertisement with the goal of evaluating how they view them. Although this may not be the best strategy for understanding the impacts of advertisements, it gives an incredible understanding of the implications inferred.

Deceptive advertisements are slight misrepresentations of the real qualities of a product. Opinionated articulations might additionally fall under this class. The use of expressions like "the best or greatest" is recognized as 'sales talk' and cannot be controlled. These wide explanations are subjective and not particularly convincing. This acknowledgement can also cause issues when the line between deception and exaggeration is not clearly identified. A few advertisers might consider that their advertisements are not tricky, but only misrepresentations or subjective representations (Dukes, 2006). Such aspects may often disregard the need to enhance product safety for the good of consumer health and protection of the environment.

Unfairness

The FTC is additionally answerable for managing unfair practices in advertising. Although the deception may be a form of unfairness, it is conceivable for advertisers to justify their messages to purchasers. These obligations of the FTC enhance the Commission's ability to regulate a wide range of advertising practices. In such scenarios, the FTC characterizes unfairness to include immoral, exploitative, abusive, or unscrupulous behaviors. Such a general definition creates excessively broadened measure of authority (Palmer, 2010). Historically, the FTC redefined its degree in its Policy Statement on Unfairness. After much debate with respect to the extent of the FTC, the FTC Act Amendments of 1994 made some significant changes to certain key terms (Cheeseman, 2010). For example, the expression of unfairness was redefined again with the aim of incorporating a more defined and centered concept. Eventually, the definition was made to include acts that conceivably cause unavoidable and considerable harm but not exceeding the overall benefit to consumers.

Advertising and Children

Children are of special interests to most people engaged in advertising. Various issues of advertising ethics and laws emerge from the potential impacts that advertisements can have on children. There has been some movement relating to advertising and youngsters: they remain secured by regulating organizations. Television is a major means through which advertisers reach and convince children. The Federal Communications Commission (FCC) is also answerable for supervising and controlling advertisements directed young viewers.

Some regulations are included in safeguarding children from conceivably negative commercials that sometimes borders on unconstitutionality. Although this may be a significant effort to counteract kids from being obstinately affected, it raises crucial inquiries and issues about the constitution and advertising. If misused, this enthusiasm to protect children may be utilized to avoid certain legal regulations and standards.

Direct-to-Consumer (DTC) marketing by drug companies

Although DTC advertising educates patients, it may also misguide them. A common issue is that DTCPA discards vital details. DTCPA furthermore will recommend that health change comes from medicine along with healthy exercises but not from behavior adjustment alone. Patients might furthermore lack the skills required to evaluate thorough therapeutic details even after being equipped with the same. This is because the content in DTCPA frequently exceeds the eighth-grade level of education, which is normally suggested for details conveyed to the overall population. Moreover, few lay people have the developed capabilities required to evaluate the reasoning, mindset, commercial concerns, and language used in DTCPA. Customers have also been found to trust many DTC ads needlessly. One study of customers found that half of participants thought that the government approved the ads. Fifty percent thought that a solution must be very safe for it to be publicized, and twenty-two percent alleged that drugs known to have authentic signs could not be promoted (Palmer, 2010).

The development of details about threats and adverse responses in DTCPA might furthermore enhance and needless worry of responses. This concern has been conveyed by doctors and the defenders of DTCPA calling for further deregulation. In their opinion, the required risk alerts are extreme to the point that they cause shoppers needless worry about drugs safety and levels of resistance. Furthermore, the rules of the FDA do not address the use of appropriate advertising terminology. However, details in DTC ads are consistently portrayed in uncertain and qualitative terms that misrepresent the level of drug benefits. Qualifying terminology concerning signs might be misdirecting and open to various perceptions because of the employment of expressions like short periods. It has been found that details that utilize determining the terminology to provide responses help the benefit, and not the risk side of the fair balance formula. They reduce the risk potential connected to drugs. Risk details are furthermore consistently losing quantitative details with respect to the incident of unfavorable results; studies indicated that it might support customers in analyzing the threats associated with drugs.

Who regulates compounding pharmacies under the current regulatory scheme?

Compounding pharmacies are long-standing yet not much talked about in the drug manufacturing, distribution, and the patient utilization sector. The term alludes to any physical drug pharmacy authorized to blend or "compound" chemical ingredients into a fulfilled medicine primed for use by a patient while following a prescription given by a medical practitioner or any lawfully approved prescriber. The elected Food and Drug Administration (FDA) controls all the commercial pharmaceutical manufacturers. In any case, the government is the essential controller of pharmacies, including the group "drug stores," vast chains, in-store drug pharmacy counters and specialty pharmacies (Palmer, 2010).

Each state has laws and regulations controlling pharmacies requirements and standards, tending to issues like obliged licenses for every facility, the credentialed drug specialists, and different representatives working there. Each jurisdiction has prerequisites for secure storage, record keeping, the forms utilized for patient prescriptions, labeling and safety protocols identified with credibility, expiration dates of items, sterility, purity and space among other factors. This includes the additional power conceded to "compound" or blend pharmaceutical parts into a patient-primed item. Various existing compounding pharmacies have the power to prepare such items for patients considering the medicines composed by specialists or different prescribers. Some of these practice provisions date back to five decades ago. Many drug producers assumed diminutive roles in the prescription and medication. State rules are overhauled intermittently normally under the purview of singular state Boards of Pharmacy working in the fifty states (Weiss, 2009).

Ethical considerations of PharmaCARE's use of Colberian intellectual property from all the theories

All the theories are pertinent in protecting the thought of human dignity. Even with their distinct methodology concerning their arrangement of "the good," PharmaCARE is essentially concentrated on building a route encouraging the well-being of all individuals. When connected, the theories show that PharmaCARE should administer thorough standards of rationality, to uphold in general comprehension of "the good," and follow a great plan. With the existence of a defined goal, it must not succumb to self-centeredness or want-reward situations. While practicing sympathy, is important to put itself in the shoes of Colberian whilst acknowledging that everyone deserves good things (Keillor & Wilkinson, 2011).

Kantian deontology holds that we must sincerely desire to do well for ourselves and to others. Such a reason allows PharmaCARE to choose an activity that is sincerely good and most valuable for all groups. Kant thought that we often focus on the results when our ethical actions have all-inclusive events. This enables us to understand the potential effect of our choices and using them when interacting with others. Therefore, the company must understand how its activities might influence other stakeholders within the industry.

From a utilitarian stance, by distinguishing one's immediate value, PharmaCARE considers them enough to address their need for satisfaction, and choose the best compromise, which meets all the preferences of a pleasurable life. In this case, pushing the harm or suffering of another human being is wholly wrong since there is no benefit at all. A discipline that does not help to stop more negativity has no good: an individual, being qualified for a good life, is constantly disgraced. In the event that lack of regard for the unconditional human rights is continuously utilized, it will perpetuate the development of misery among human beings. Utilitarianism shields dignity by supporting our right and yearning for a pleasurable presence and by concentrating on what will be most helpful to the most individuals. With this, our human rights are largely comprehended and must be met productively.

With the thought of universal respect, anyone should be treated well and live in a planet free from any unfair treatment. The theories focus on mapping out a route with which we can attain fulfillment of ourselves and achieve our desired objectives while being accommodative to others. While setting justifiable legal obligation, PharmaCARE must strive to do what is right from Colberian's view. In a perfect scenario, one must not overuse someone's wellness even if it is compatible with "the good." This might also refer to a prosperous social order and the chance for a fulfilling presence. The comprehension that human life is full of incredible worth remains one bond in characterizing and persuading the all-inclusive understanding of "the good," paying little heed to which moral theory is connected. Without it, the concepts of Kantian deontology, utilitarianism, and ethics of care might lose much of their purpose and meaning.

How PharmaCARE uses the U.S. law to protect its intellectual property while co-opting Colberia's?

The U.S. government provides patents to pharmaceutical companies. PharmaCARE has rights to buy and make generics under the TRIPS agreement under the WTO. Article 31 of the TRIPS law allows countries to identify what is considered as a "compulsory permit" strengthening PharmaCARE in making a deal under certain circumstances like nationwide programs. The main condition is that they make an effort to organize sufficient business conditions with the certain owner: if it drops to "satisfactorily" payback, the owner for usage of innovation is adopted. PharmaCARE will adopt this concept in Colberia's situation (Cheeseman, 2010).

Ways the organization could make up the individuals and country of Colberia for the use of its ip and destruction to its environment

The transaction for certain encroachment is identified depending upon the actual failures of individuals and country of Colberia. This strategy is reliable with the important guide for identifying encroachment compensation in Colberia. The essential solution for encroachment of residence privileges and financial commitment relates to "full re-establishments." For instance, it is expected that in case residences or residence that belong to individuals and country of Colberia are embezzled, it should be reverted to the owners (Cheeseman, 2010). In the occasion that such residence cannot be reverted, compensation in terms of cash is accepted. Should the individuals and country of Colberia maintain further authentic damages as the impacts of encroachment, the organization may also make up for such damages." Article 19 of the Tort Responsibility Law offers that "Property failures because of residential encroachment must be considered reliable with the rate or by other appropriate means at the time the dangers were triggered." The procurements for certain encroachment under the Patent Law have adopted the same important requirements. The responsibility of the infringing party is restricted to dealing with the failures of the citizens and country of Colberia. It is not enhanced to corrective settlement.

From a legal perspective, the law regulating certain violation and settlement plans allows the citizens of Colberia recover from the damages and from the circumstances they might have experienced in case of a violation. In fact, the laws allow individuals and country of Colberia to provide evidence indicating their actual failures, the infringers' benefits or sensible fame. Besides, the conventional of evidence in a common situation must be reduced than in a lawful arraignment. Any possibility linked instead of the "past a sensible mistrust" is conventional. Consequently, evidence indicating the destruction of a person's reliable resources is required if proper compensation protocols have to be observed. .

Compare PharmaCARE's actions with those of at least one (1) real-world company whose creativity in skirting legal technicalities led to ethical lapses and financial loss

The U.S. has not issued a mandatory permit for a patented medication. Mandatory licensing creates grave dangers to exchange and dangers of prosecution. Some recent cases outline the peril: Thailand has been under compelling pressure from the USTR to shun issuing mandatory permits allowing it to make a generic version of AZT. Besides, a group of 39 pharmaceutical organizations sued the South African government when it attempted to reinforce a law authorizing the lawful operations of USTR in 1998 (Keillor & Wilkinson, 2011). Brazil has a patent on a Merck Aids pill called Stocrin, yet it started importing a generic version made in India called efavirenz. When the Brazilians consumers threatened Merck with a mandatory permit for Stocrin unless Merck brought down its value, the organization opted to sue the government and the WTO. The three scenarios led to great financial losses to the companies.